Geneious Prime Enterprise Licenses

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Graphpad Software LLC for the purchase of Geneious Prime Enterprise Academic Yearly Subscription, 200 seats. The Government desires to obtain the Geneious Prime software licensing because it is part of several validated CLIA test protocols. The anticipated period of performance is 2/23/2026 through 2/22/2031 and will include four one-year option periods. • The contract is for software licensing and support. • The Government is not able to modify the validated protocols due to the amount of time and cost required. • Interested vendors may identify their interest and capability to respond to the requirement or submit proposals. • Any quotation/response should be emailed to the Contracting Officer by 5:00PM (ET) on 12/16/2025.